EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect

Hongyang Deng iD, Jiaxing Zhang, Fahong Wu iD, Fengxian Wei, Wei Han, Xiaodong Xu, Youcheng Zhang

Cancers · 11.02.2023 · 15 (4) · 1169

DOI: 10.3390/cancers15041169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.02.2023. Verfasst von Hongyang Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technique Innovation Project of Lanzhou University Second Hospital, the Doctoral Supervisors Research Fund of Lanzhou University Second Hospital, Gansu Provincial Science Foundation for Young Scholars of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lymphatic system is a channel for fluid transport and cell migration, but it has always been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has long been recognized as a major molecular driver of lymphangiogenesis. However, many studies have shown that the neural network of lymphatic signaling is complex. Lymphatic vessels have been found to play an essential role in the immune regulation of tumor metastasis and cardiac repair. This review describes the effects of lipid metabolism, extracellular vesicles, and flow shear forces on lymphangiogenesis. Moreover, the pro-tumor immune tolerance function of lymphatic vessels is discussed, and the tasks of meningeal lymphatic vessels and cardiac lymphatic vessels in diseases are further discussed. Finally, the value of conversion therapy targeting the lymphatic system is introduced from the perspective of immunotherapy and pro-lymphatic biomaterials for lymphangiogenesis.

Schlagwörter

Stichwörter der Autor:innen

immune toleranceimmunotherapylymphangiogenesismeningeal lymphatic vesselsmyocardial infarctiontumor metastasis

Autor:innen und Institutionen

  • Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
  • Key Laboratory of the Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China.

ORCID-Profile: Hongyang Deng, Fahong Wu

Förderung

  • the Science and Technique Innovation Project of Lanzhou University Second Hospital
  • the Doctoral Supervisors Research Fund of Lanzhou University Second Hospital
  • Gansu Provincial Science Foundation for Young Scholars of China
  • Cuiying Technology Innovation Project of Lanzhou University Second Hospital
  • Doctoral Students Training Research Fund of Lanzhou University Second Hospital

Zitieren

APA

Deng, H., Zhang, J., Wu, F., Wei, F., Han, W., Xu, X., & Zhang, Y. (2023). Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect. Cancers, 15(4), 1169. https://doi.org/10.3390/cancers15041169

Vancouver

Deng H, Zhang J, Wu F, Wei F, Han W, Xu X, et al. Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect. Cancers. 2023;15(4):1169. doi:10.3390/cancers15041169

BibTeX
@article{Deng2023,
  author = {Deng, Hongyang and Zhang, Jiaxing and Wu, Fahong and Wei, Fengxian and Han, Wei and Xu, Xiaodong and Zhang, Youcheng},
  title = {Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1169},
  doi = {10.3390/cancers15041169}
}
Kostenlos starten →